Merck KGaA (LON:0O14)

Market Cap	53.32B +23.2%
Revenue (ttm)	18.20B -0.4%
Net Income	2.04B -17.2%
EPS	4.57 -17.3%
Shares Out	n/a
PE Ratio	26.96
Forward PE	16.89
Dividend	1.92 (1.56%)
Ex-Dividend Date	Apr 27, 2026

Volume	14,706
Open	142.00
Previous Close	142.25
Day's Range	141.60 - 147.55
52-Week Range	100.70 - 148.50
Beta	0.79
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Merck KGaA

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1668
• Employees: 62,136
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O14

Financial Performance

In 2025, Merck KGaA's revenue was 21.10 billion, a decrease of -0.26% compared to the previous year's 21.16 billion. Earnings were 2.61 billion, a decrease of -6.09%.

Financial numbers in EUR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 22, 2026

Data Sources Report a data error